phenoxybenzamine has been researched along with Prostatic Hyperplasia in 40 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Excerpt | Relevance | Reference |
---|---|---|
"A prospective study was conducted in a community hospital in order to evaluate the therapeutic effect of dibenyline, finasteride, and a combination of the two drugs for symptomatic benign prostatic hyperplasia (BPH)." | 9.08 | Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia. ( Kuo, HC, 1998) |
"Nine patients with bladder outlet obstruction attributable to benign prostatic hyperplasia were treated with 15 mg of phenoxybenzamine daily." | 7.66 | Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation. ( Blaabjerg, J; Clausen, S; Gerstenberg, T; Nielsen, ML, 1980) |
"A prospective study was conducted in a community hospital in order to evaluate the therapeutic effect of dibenyline, finasteride, and a combination of the two drugs for symptomatic benign prostatic hyperplasia (BPH)." | 5.08 | Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia. ( Kuo, HC, 1998) |
"Nine patients with bladder outlet obstruction attributable to benign prostatic hyperplasia were treated with 15 mg of phenoxybenzamine daily." | 3.66 | Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation. ( Blaabjerg, J; Clausen, S; Gerstenberg, T; Nielsen, ML, 1980) |
"Medical management of benign prostatic hyperplasia (BPH) is an alternative to surgical treatment of this disease." | 1.29 | Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate. ( Breslin, D; Chou, TC; Felsen, D; Fields, DW; Kane, M; Marion, DN; Vaughan, ED, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (75.00) | 18.7374 |
1990's | 8 (20.00) | 18.2507 |
2000's | 2 (5.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Te, AE | 1 |
Bouffioux, CR | 1 |
Penders, L | 1 |
Gerstenberg, T | 1 |
Blaabjerg, J | 1 |
Nielsen, ML | 1 |
Clausen, S | 1 |
Caine, M | 10 |
Perlberg, S | 4 |
Shapiro, A | 1 |
Lardennois, B | 1 |
El Khansa, A | 1 |
Amory, JP | 1 |
Coulon, JM | 1 |
Lemaire, P | 1 |
Flamm, J | 1 |
Abrams, PH | 2 |
Shah, PJ | 2 |
Stone, R | 2 |
Choa, RG | 2 |
Abrams, P | 1 |
Hollister, P | 1 |
Lawrence, J | 1 |
Doyle, PT | 1 |
Sherwood, T | 1 |
Whitaker, RH | 1 |
Wu, JP | 1 |
Gu, FL | 1 |
Lu, EX | 1 |
Brooks, ME | 2 |
Sidi, AA | 1 |
Hanani, Y | 1 |
Braf, ZF | 1 |
Braf, ZE | 1 |
Griffiths, DJ | 1 |
Schröder, FH | 1 |
Reuther, K | 1 |
Aagaard, J | 1 |
Vela-Navarrete, R | 1 |
Breslin, D | 1 |
Fields, DW | 1 |
Chou, TC | 1 |
Marion, DN | 1 |
Kane, M | 1 |
Vaughan, ED | 1 |
Felsen, D | 1 |
Brawer, MK | 1 |
Lepor, H | 1 |
Gómez Sancha, F | 1 |
Fernández Arjona, M | 1 |
Peinado Ibarra, F | 1 |
Fernández Borrell, A | 1 |
Mínguez Martínez, R | 1 |
Pereira Sanz, I | 1 |
Kuo, HC | 1 |
Altwein, JE | 1 |
Meretyk, S | 2 |
Pfau, A | 1 |
Boreham, PF | 1 |
Braithwaite, P | 1 |
Milewski, P | 1 |
Pearson, H | 1 |
Kondo, A | 1 |
Narita, H | 1 |
Otani, T | 1 |
Kobayashi, M | 1 |
Takita, T | 1 |
Bellows, JG | 1 |
Perrigot, M | 1 |
Vannier, A | 1 |
Bor, Y | 1 |
Goodwin, MI | 1 |
Chester, JF | 1 |
Jenkins, JD | 1 |
Ferrie, BG | 1 |
Paterson, PJ | 1 |
Chen, KK | 1 |
Chang, LS | 1 |
Chen, MT | 1 |
Huang, JK | 1 |
Yin, JH | 1 |
Lin, SN | 1 |
Lin, AD | 1 |
Staub, WR | 1 |
Staub, JS | 1 |
Tachev, S | 1 |
Petrov, P | 1 |
Simeonov, P | 1 |
9 reviews available for phenoxybenzamine and Prostatic Hyperplasia
Article | Year |
---|---|
A modern rationale for the use of phenoxybenzamine in urinary tract disorders and other conditions.
Topics: Adrenergic alpha-Antagonists; Animals; Clinical Trials as Topic; Half-Life; Humans; Male; Phenoxyben | 2002 |
Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Labetalol; Male | 1984 |
The role of alpha 1-blockade in benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aging; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prazo | 1993 |
Medical therapy for benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Anilides; Clinical | 1993 |
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prosta | 1997 |
Obstructive benign prostatic hyperplasia: therapeutical aspects.
Topics: Adrenergic alpha-Antagonists; Combined Modality Therapy; Costs and Cost Analysis; Enzyme Inhibitors; | 1998 |
Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prostate; Pr | 1990 |
The place of pharmacologic treatment in benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Urination Disor | 1985 |
Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Phenoxybenzamine; Prazosin; Prostate; Prostatic Hyperpla | 1988 |
13 trials available for phenoxybenzamine and Prostatic Hyperplasia
Article | Year |
---|---|
Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Labetalol; Male | 1984 |
Bladder outflow obstruction treated with phenoxybenzamine.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Phenoxybenzamine; Pr | 1981 |
Bladder outflow obstruction treated with phenoxybenzamine.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Phenoxybenzamine; Pr | 1982 |
Bladder outflow obstruction treated with phenoxybenzamine. Preliminary note.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Humans; Male; Mid | 1982 |
Ineffectiveness of phenoxybenzamine in treatment of benign prostatic hypertrophy. A controlled study.
Topics: Adult; Aged; Clinical Trials as Topic; Humans; Male; Middle Aged; Phenoxybenzamine; Pressure; Prosta | 1983 |
Phenoxybenzamine in prostatic obstruction.
Topics: Aged; Double-Blind Method; Drug Evaluation; Humans; Male; Middle Aged; Phenoxybenzamine; Pressure; P | 1984 |
Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Follo | 1998 |
Alpha-adrenergic blockers in prostatism.
Topics: Chronic Disease; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Ti | 1977 |
A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia | 1978 |
Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prostate; Pr | 1990 |
Acute urinary retention secondary to benign prostatic hyperplasia. Effect of alpha-adrenergic blockade.
Topics: Adult; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Phenoxybenzamine; Prostatic Hyperplasia; | 1986 |
Phenoxybenzamine in prostatic hypertrophy. A double-blind study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Phenoxybenzam | 1987 |
Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; P | 1988 |
20 other studies available for phenoxybenzamine and Prostatic Hyperplasia
Article | Year |
---|---|
Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
Topics: Aged; Cystoscopy; Humans; Male; Phenoxybenzamine; Pressure; Prostatic Hyperplasia; Urinary Bladder N | 1980 |
Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases.
Topics: Adult; Age Factors; Aged; Humans; Male; Middle Aged; Phenoxybenzamine; Physical Examination; Prostat | 1981 |
[Phenoxybenzamine in prostatic pathology. 300 cases (author's transl)].
Topics: Acute Disease; Adrenergic alpha-Antagonists; Humans; Male; Phenoxybenzamine; Placebos; Prostatic Hyp | 1981 |
[Conservative therapy of prostate adenoma with phenoxybenzamine. Clinical aspects and urodynamics].
Topics: Aged; Humans; Male; Middle Aged; Phenoxybenzamine; Prognosis; Prostatic Hyperplasia; Urination Disor | 1981 |
Effects of phenoxybenzamine and prostigmine relative voiding resistance in patients with benign prostatic hypertrophy.
Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Humans; Male; Middle Aged; Neostigmine; Phenoxybenz | 1983 |
Phenoxybenzamine for symptoms of bladder neck obstruction.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; | 1983 |
Phenoxybenzamine in benign prostatic hypertrophy.
Topics: Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia | 1983 |
Phenoxybenzamine and benign prostatic hypertrophy.
Topics: Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Urodynamics | 1984 |
Alpha-adrenergic blockade in the diagnosis of detrusor instability secondary to infravesical obstruction.
Topics: Aged; Humans; Male; Mechanoreceptors; Middle Aged; Phenoxybenzamine; Prostatic Hyperplasia; Urinary | 1984 |
BPH alpha blocker therapy.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia | 1995 |
Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate.
Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Epinephrine; Male; Mu | 1993 |
A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. 1978.
Topics: Adrenergic alpha-Antagonists; History, 20th Century; Humans; Male; Phenoxybenzamine; Prostatic Hyper | 2002 |
The use of alpha-adrenergic blockers in benign prostatic obstruction.
Topics: Aged; Humans; Male; Middle Aged; Phenoxybenzamine; Phentolamine; Prostatic Hyperplasia; Urination Di | 1976 |
[Urodynamic study of lower urinary tract. VI. Clinical application of alpha adrenergic blocker for the treatment of benign prostatic hypertrophy and bladder neck contracture (author's transl)].
Topics: Adrenergic alpha-Antagonists; Aged; Contracture; Humans; Male; Middle Aged; Phenoxybenzamine; Prosta | 1978 |
Phenoxybenzamine for benign prostatic hypertrophy.
Topics: Aged; Humans; Male; Middle Aged; Phenoxybenzamine; Prostatic Hyperplasia | 1979 |
Phenoxybenzamine for benign prostatic hypertrophy.
Topics: Dose-Response Relationship, Drug; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia | 1979 |
[Alpha adrenergic blocking agents in disorders of the bladder sphincter].
Topics: Adrenergic alpha-Antagonists; Adult; Female; Humans; Male; Moxisylyte; Nicergoline; Phenoxybenzamine | 1986 |
Medical management of prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aging; Bromocriptine; Cyproterone; Humans; Male; Phenoxybenzamin | 1986 |
Phenoxybenzamine in benign prostatic obstruction.
Topics: Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Urination | 1988 |
[Therapeutic potentials of the preparation dibenziran in patients with prostatic adenoma].
Topics: Aged; Drug Evaluation; Humans; Male; Middle Aged; Phenoxybenzamine; Prostatic Hyperplasia; Urodynami | 1988 |